Han Albert Y, Kuan Edward C, Mallen-St Clair Jon, Badran Karam W, Palma Diaz Miguel F, Blackwell Keith E, St John Maie A
Department of Head and Neck Surgery, Los Angeles, California.
Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco Medical Center, San Francisco, California, U.S.A.
Laryngoscope. 2019 May;129(5):1087-1092. doi: 10.1002/lary.27579. Epub 2019 Jan 22.
OBJECTIVES/HYPOTHESIS: To characterize the demographics, clinicopathologic characteristics, and treatment and reconstructive outcomes of patients who underwent total glossectomy STUDY DESIGN: Retrospective chart review at an academic tertiary-care medical center.
All patients who had undergone total glossectomy (as an individual procedure or as part of a more extensive resection) between January 1, 1995 and December 31, 2014 were included in the analysis. Patient characteristics and clinical outcomes were reviewed.
Forty-eight patients underwent total glossectomy for oral tongue and base of tongue cancer. The mean age of the patients was 56 (range, 29-92 years). History of tobacco and heavy alcohol use was found in 76% and 11% of patients, respectively. The majority of patients had advanced cancer (91.7% at stage IV), and 60.4% had salvage therapy for recurrent disease. T4 disease comprised 81% of patients. Sixty percent had clinical or radiographic evidence of nodal metastasis. Reconstruction of the defect was performed with free flaps from the rectus abdominus (40%), fibula (25%), anterolateral thigh (23%), and other donor tissues. One- and 5-year survival rates were 42% and 26%, with locoregional and distant recurrence reported at 36% and 25%, respectively.
Total glossectomy for oncologic control is most commonly performed in patients who have stage IV cancers. Despite high reconstructive success rates, the likelihood of locoregional and distance recurrence was high. Most patients can communicate intelligibly and achieve decannulation, but swallowing outcomes remain guarded, especially considering previous irradiation and resection of the base of tongue.
4 Laryngoscope, 129:1087-1092, 2019.
目的/假设:描述接受全舌切除术患者的人口统计学特征、临床病理特征以及治疗和重建结果。研究设计:在一家学术性三级医疗中心进行回顾性病历审查。
纳入1995年1月1日至2014年12月31日期间接受全舌切除术(作为单独手术或更广泛切除术的一部分)的所有患者进行分析。回顾患者特征和临床结果。
48例患者因口腔舌癌和舌根癌接受了全舌切除术。患者的平均年龄为56岁(范围29 - 92岁)。分别有76%和11%的患者有吸烟和大量饮酒史。大多数患者患有晚期癌症(IV期占91.7%),60.4%的患者因复发性疾病接受了挽救性治疗。T4期疾病患者占81%。60%的患者有临床或影像学证据显示有淋巴结转移。采用腹直肌游离皮瓣(40%)、腓骨(25%)、股前外侧皮瓣(23%)和其他供体组织对缺损进行重建。1年和5年生存率分别为42%和26%,局部区域复发率和远处复发率分别为36%和25%。
为控制肿瘤而进行的全舌切除术最常用于IV期癌症患者。尽管重建成功率较高,但局部区域和远处复发的可能性仍然很高。大多数患者能够清晰交流并拔管,但吞咽结果仍不容乐观,尤其是考虑到既往有放疗和舌根切除史。
4 《喉镜》,2019年,第129卷,第1087 - 1092页